These include 12 proteins of the acute phase response such as SAA1 and LBP, and 12 proteins involved in coagulation, including FGB and SERPINA4, all of which have been found to be differentially expressed depending on COVID‐19 disease severity. This evidence concerns the gene SERPINA4 and COVID-19.